Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: ALTURiX Ltd, 287 Upper Fourth Street, Milton Keynes, MK9 1EH UK
NACSYS 600 mg effervescent tablets.
| Pharmaceutical Form |
|---|
|
Effervescent tablet. Round, flat, white to yellowish effervescent tablet (1500 mg/tablet; ~ 17 × 4.25mm). |
Each effervescent tablet contains 600 mg of acetylcysteine.
Excipient(s) with known effect: contains sodium hydrogen bicarbonate (E500) (equivalent to 115 mg of sodium).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acetylcysteine |
Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions. |
| List of Excipients |
|---|
|
Sodium hydrogen carbonate (E500) |
The tablet container(s) are packaged in cardboard boxes. The box contains 6, 2x6, 10, 2x10, 20 or 3x10 effervescent tablets.
The effervescent tablets are packaged in a propylene tube with a polyethylene cap and a desiccant.
Not all pack sizes may be marketed.
ALTURiX Ltd, 287 Upper Fourth Street, Milton Keynes, MK9 1EH – UK
PL 44490/0006
11/05/2017
| Drug | Countries | |
|---|---|---|
| NACSYS | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
